In the cytoplasm, ligand‐bound AR interacts with protein kinases such as SRC and PI3K via its N terminus to initiate signal transduction pathways that modulate cellular proliferation and migration in prostate cancer cell lines. Here, AR is linked to prostate carcinoma.